Clinical Trial Update: Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports on the effectiveness and duration of effect of open-label lisdexamfetamine dimesylate (Vyvanse) in patients with attention-defi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: NYU Langone Health | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-11-25